Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
P/S ratio for Kymera Therapeutics (KYMR)
P/S ratio as of May 2024 (TTM): 28.3
According to Kymera Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 28.3401. At the end of 2023 the company had a P/S ratio of 18.0.
P/S ratio history for Kymera Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 18.0 | -38.54% |
| 2022 | 29.2 | -34.72% |
| 2021 | 44.8 | -44.69% |
| 2020 | 81.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |